Option chain shows key data for Zivo Bioscience's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Zivo Bioscience.

Zivo Bioscience (OTC:ZIVO) Stock, Option Chain

Zivo Bioscience

Zivo Bioscience Inc is a research and development company operating in both the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's candidates are Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Companion Animal Food Ingredient, NDI (New Dietary Ingredient, and Skin Health.

Long Ideas

News

Penny Stocks

Small Cap

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

OCFC

SFBC

ZIVO

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

$2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

Intraday Update

Movers

ACCD

AULT

BENF

BROG

BTTR

BTWN

CMBM

CNTB

EURN

FSLY

GROM

IPDN

ISPO

LGVN

MKUL

MNTS

MSGM

MXCT

NBTX

NKGN

OGEN

OKYO

Grupo Aeroportuario del Centro NorteB de CV

OMAB

ORTX

RIVN

SGML

SNES

VEON

VINO

VSME

WHLR

XRTX

Gainers


	Orchard Therapeutics plc  (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan&#39;s Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent value right of $1.00 per ADS.


Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

APPH

BRCC

SMFL

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Top 5 Defensive Stocks Which Could Rescue Your Portfolio For July

ZIVO BIOSCIENCE INC by Zivo Bioscience, Inc.

Zivo Bioscience Inc

Zivo Bioscience Inc Warrants (29/04/2026)

Press Releases

Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience's Coccidiosis Treatment in Broiler Chickens

ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens

ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza

ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities

ZIVO Bioscience to Present at The Microcap Conference 2025

ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry

Comments

Zivo Bioscience

Zivo Bioscience (ZIVO) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell